Ocean Biomedical Scientific Co-founder Dr. Jack Elias To Be Issues US Patent Titled 'METHODS AND COMPOSITIONS RELATING TO ANTI-CHI3L1 ANTIBODY REAGENTS FOR THE TREATMENT OF CANCEr'
Portfolio Pulse from Benzinga Newsdesk
Ocean Biomedical's scientific co-founder, Dr. Jack Elias, is set to be issued a US patent for 'Methods and Compositions Relating to Anti-CHI3L1 Antibody Reagents for the Treatment of Cancer'.
June 05, 2023 | 7:42 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Ocean Biomedical's co-founder Dr. Jack Elias will be issued a US patent for anti-CHI3L1 antibody reagents, potentially benefiting the company's cancer treatment research.
The issuance of the US patent to Dr. Jack Elias, Ocean Biomedical's co-founder, for anti-CHI3L1 antibody reagents is a positive development for the company. It could potentially lead to advancements in cancer treatment research and strengthen the company's intellectual property portfolio. This news is likely to have a positive short-term impact on OCEA's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100